by
Back to overview
Blood-based biomarkers
Validated biomarkers including GFAP, UCH-L1, and NfL provide objective biological indicators associated with neurological injury. A remote self-collection kit is processed through a CLIA-certified laboratory.
Structured clinical assessment
A comprehensive clinical interview plus validated cognitive and emotional assessments of symptom patterns, functional impact, and clinical presentation.
Remote pupillometry
iPhone-compatible technology captures pupillary response remotely — a validated neurological indicator — with no in-person visit.
Signed clinical determination
A named physician, a defined diagnostic framework, and a report designed to be understandable, traceable, and defensible.
Fast turnaround
Actionable clinical information early in a case’s lifecycle — when it can still shape strategy.
Fully remote process
No clinic coordination, transportation barriers, or unnecessary delays for your client.
Lower cost than traditional testing
At , substantially less than a full neuropsychological battery — and well below what other providers charge for comparable early screening.
Clear escalation path
If further evaluation is needed, clients continue within the Rincon Neurosciences ecosystem rather than starting over.